Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0182 |
Clopidogrel
(S)-Clopidogrel,SR-25990C,氯吡格雷 |
P2Y Receptor | GPCR/G Protein; Neuroscience |
Clopidogrel (SR-25990C) 是一种 P2Y12 受体拮抗剂,可降低血小板聚集,用于抑制冠状动脉疾病、周围血管疾病和脑血管疾病中的血凝块。 | |||
T0182L |
Clopidogrel hydrogen sulfate
硫酸氢氯吡格雷,(S)-(+)-Clopidogrel hydrogen sulfate,(S)-(+)-Clopidogrel bisulfate,SR-25990C,Clopidogrel,硫酸氯吡格雷 |
P450; P2Y Receptor | GPCR/G Protein; Metabolism; Neuroscience |
Clopidogrel hydrogen sulfate ((S)-(+)-Clopidogrel bisulfate) 是一种抗血小板药物,可防止血栓形成。它抑制 CYP2B6和 CYP2C19,IC50分别为 18.2 和 524 nM。 它是一种选择性的高亲和力 P2Y12 受体拮抗剂,可抑制纤维蛋白原与血小板的结合以及血小板的粘附和聚集。 | |||
T0182L2 |
(±) Clopidogrel hydrogen sulfate
硫酸氢氯吡格雷,Plavix,Clopidogrel hydrogen sulfate,Iscover |
P2Y Receptor | GPCR/G Protein; Neuroscience |
(±) Clopidogrel hydrogen sulfate (Iscover) 是一种在药理学和结构上类似于ticlopidine 的抗血小板药物,用于抑制脑血管疾病、外周血管疾病和冠状动脉疾病等各种疾病中的血栓。 | |||
T38506 |
cis-Clopidogrel-MP derivative
cis-Clopidogrel-MP derivative,Clopidogrel-MP-AM |
||
cis-Clopidogrel-MP derivative, also known as Clopidogrel-MP-AM, is a 3’-methoxyacetophenone derivative of Clopidogrel active metabolite. This compound is an orally-active platelet inhibitor specifically targeting the P2Y12 receptor. | |||
T35431 |
(±)-Clopidogrel (hydrochloride)
|
||
Clopidogrel is an antithrombic compound whose active metabolite is a selective, irreversible antagonist of the platelet purinergic P2Y12 receptor (IC50 = 100 nM). Clopidogrel inhibits ADP-induced platelet aggregation ex vivo and functions as a prodrug whereupon biotransformation to its active metabolite via CYP2C19 in the liver enables its anti-aggregating activity. Marketed under the name Plavix , clopidogrel in combination with aspirin has been shown to be beneficial in the prevention of vascu... | |||
T36222 |
2-oxo Clopidogrel
|
||
2-oxo Clopidogrel is an intermediary metabolite of clopidogrel . Clopidogrel is a prodrug that is converted to its active metabolite via two sequential oxidative steps. The first step leads to formation of 2-oxo clopidogrel, followed by conversion to the active metabolite, which binds specifically and irreversibly to the platelet P2Y12 purinergic receptor, inhibiting ADP-mediated platelet activation and aggregation. | |||
T5501 |
Clopidogrel thiolactone
2-oxoclopidogrel |
P2Y Receptor | GPCR/G Protein; Neuroscience |
Clopidogrel thiolactone (2-oxoclopidogrel) 是一种有效的 P2Y12 受体抑制剂, 是一种有效的抗血小板聚集化合物。Clopidogrel thiolactone是Clopidogrel第一次氧化活化产生的活性代谢中间体。 | |||
T71254 |
Clopidogrel HCl
|
||
Clopidogrel HCl is the salt form of Clopidogrel (free base), an inhibitor of ADP-induced platelet aggregation acting by direct inhibition of adenosine diphosphate (ADP) binding to its receptor and of the subsequent ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. | |||
T36112 |
Clopidogrel Carboxylic Acid (hydrochloride)
|
||
Clopidogrel is an antithrombic compound whose active metabolite is a selective, irreversible antagonist of the platelet purinergic P2Y12 receptor (IC50 = 100 nM). Clopidogrel inhibits ADP-induced platelet aggregation ex vivo and functions as a prodrug whereupon biotransformation to its active thiol metabolite via CYP2C19 in the liver enables its anti-aggregating activity. An estimated 15% of administered clopidogrel is metabolized by CYP2C19 to the thiol metabolite. Clopidogrel carboxylic acid i... | |||
T125853 |
Clopidogrel Related Compound A
|
||
Clopidogrel Related Compound A 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 T125853,CAS号为 144457-28-3。 | |||
T125846 |
Clopidogrel Related Compound B
|
||
Clopidogrel Related Compound B 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 T125846,CAS号为 144750-52-7。 | |||
T126236 | Clopidogrel Related Compound C | ||
Clopidogrel Related Compound C 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 T126236,CAS号为 120202-71-3。 | |||
T0179 |
Ticagrelor
替格瑞洛,替卡格雷,AR-C 126532XX,AZD6140 |
P450; P2Y Receptor | GPCR/G Protein; Metabolism; Neuroscience |
Ticagrelor (AR-C 126532XX) (AZD6140) 是可逆的,可口服的 P2Y12受体拮抗剂,可抑制血小板聚集。 | |||
T21059 |
Ticagrelor metabolite M5
Ticagrelor metabolite M5,,T437700,替格瑞洛杂质H,AR-C133913XX |
P2Y Receptor | GPCR/G Protein; Neuroscience |
Ticagrelor metabolite M5 (T437700) 是 Ticagrelor 的代谢物,是 P2Y12 受体的第一个可逆口服拮抗剂。与氯吡格雷相比,替格瑞洛对 ADP 受体具有更快和更一致的抑制作用。替格瑞洛用于治疗急性冠状动脉综合征(ACS)。 | |||
T71363 | ACT-281959 | ||
ACT-281959, a prodrug of ACT-246475, is a novel potent and selective P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than Clopidogrel. ACT-281959 showed antithrombotic efficacy after oral administration in the rat ferric chloride model. ACT-281959 entered clinical studies in healthy volunteers. | |||
T20765 |
Atorvastatin
阿托伐他汀,阿伐他汀 |
HMG-CoA Reductase; Autophagy | Autophagy; Metabolism |
Atorvastatin 是一种具有口服活性的 HMG-CoA 还原酶抑制剂,通过激活肝细胞色素p450加快代谢,具有有效降低血脂的能力。Atorvastatin 以 IC50 值分别为 0.39 μM 和 2.39 μM 来抑制人 SV-SMC 细胞的增殖和侵袭。Atorvastatin 与氯吡格雷同时服用两种可能会导致患者血栓事件增加。 | |||
T75242 |
Bivalirudin TFA
|
||
Bivalirudin TFA 是20个氨基多肽,可逆地抑制凝血酶。 |